Xconomy National

Archives

by in

Entry	Author	Date	Location
Bristol-Myers Acquires Amira Pharmaceuticals for $325 Million, Scoops Up Lung Drug	Luke Timmerman	07/21/11	San Diego
Theravance, Glaxo Lung Drug Passes Two Pivotal Trials; Two More to Go	Luke Timmerman	06/02/11	San Francisco
Rigel Pockets $130M in Financing, Seeks To Pick up Pfizer’s Ball and Run With it	Luke Timmerman	05/26/11	San Francisco
Report: AstraZeneca to Lay Off 135 in MA	Gregory T. Huang	05/19/11	Boston
Pfizer Hands Back Rigel Drug	Luke Timmerman	05/06/11	San Francisco
Isis Spinoff Altair Therapeutics Shut Down, After Mid-Stage Asthma Study Fails	Luke Timmerman	02/03/11	San Diego
FDA Approves Sunovion Schizophrenia Drug	Erin Kutz	10/29/10	Boston
Amylin Regroups From FDA Smackdown, CalciMedica Plans Trial of New Anti-Immune Drug, FDA Gives CareFusion Recall Highest Priority, & More San Diego Life Science News	Bruce V. Bigelow	10/21/10	San Diego
Boston Scientific to Inhale Asthmatx in $194M Buyout	Ryan McBride	09/20/10	Boston
NKT Brings In $4M	Erin Kutz	08/25/10	Boston
How to Find Balance in Biotech, Between Owning It All or Finding a Partner	Bob Baltera	06/16/10	San Diego
Acton Pharmaceuticals Snares $15M for Inhaled Asthma Drug	Luke Timmerman	01/06/10	Boston
Novartis Parts Ways with Idera Pharma	Ryan McBride	11/25/09	Boston
Isis Spinoff Altair Therapeutics Closes $17M Venture Round For Asthma Drug	Luke Timmerman	11/12/09	San Diego
Pulmatrix Scores $30M To Block All Sorts of Bugs That Make People Sick in the Lungs	Luke Timmerman	11/02/09	Boston
AstraZeneca Plans Local Job Cuts, Report Says	Ryan McBride	09/11/09	Boston
Pulmatrix, With One Drug for Multiple Bugs, Aims to Fundamentally Change Flu Treatment	Luke Timmerman	06/09/09	Boston
NKT Therapeutics Aims For Severe Asthma, Targeting Natural Killer T Cells	Ryan McBride	05/18/09	Boston
Altair Therapeutics Changes CEO	Juha-Pekka Tikka	05/14/09	San Diego
Calistoga Raises $30M to Develop Drugs for Cancer, Inflammation	Luke Timmerman	05/05/09	Seattle
Axikin Raises $3M After Spinning Out From Actimis	Ryan McBride	01/22/09	San Diego
KaloBios Gets $12M Genzyme, Baxter	Luke Timmerman	12/22/08	Boston
Oral Pill May Make Tough-to-Deliver RNAi Drugs Go Down Easy, RXi Says	Luke Timmerman	11/13/08	Boston
Calistoga Builds Cancer Drug Strategy, Hires First CEO, Carol Gallagher	Luke Timmerman	10/08/08	Seattle
MPM Capital, World’s Biggest Healthcare VC Fund, Balances Startups With Stocks	Luke Timmerman	10/07/08	Boston
Idera Receives Milestone Payment from Novartis For Asthma and Allergy Collaboration	Luke Timmerman	09/02/08	Boston
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge	Luke Timmerman	08/14/08	Boston
Resolvyx Experiment Shows Fish-Oil Derivative Tamps Down Asthma, Inflammation	Luke Timmerman	07/03/08	Boston
Page 1 of 1